CIK 0001326732 · Accelerated filer
Xencor Inc
Sign in to watch- Ticker
- XNCR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 201622502
- Phone
- 626-305-5900
- Business address
- 465 N. HALSTEAD ST., SUITE 200, PASADENA, CA, 91107
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,591,617
- in 2 filings
Net −$3,591,617. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-12 | Desjarlais John R SR. VICE PRESIDENT & CSO | Option exercise 10b5-1 | +12,774 | $15.69 | $200K | 212,878 |
| 2024-11-12 | Desjarlais John R SR. VICE PRESIDENT & CSO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,774 | 3,542 | ||
| 2024-11-11 | Desjarlais John R SR. VICE PRESIDENT & CSO | Option exercise 10b5-1 | +68,684 | $15.69 | $1.1M | 268,788 |
| 2024-11-11 | Desjarlais John R SR. VICE PRESIDENT & CSO | Sale 10b5-1 | −68,684 | $23.48 | $1.6M | 200,104 |
| 2024-11-11 | Desjarlais John R SR. VICE PRESIDENT & CSO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −68,684 | 16,316 | ||
| 2024-09-27 | ROSA-BJORKESON DAGMAR Director | Sale | −2,503 | $20.68 | $52K | 8,490 |
| 2024-09-27 | RANIERI RICHARD J Director | Sale | −2,503 | $20.68 | $52K | 8,490 |
| 2024-09-27 | GUSTAFSON KURT A Director | Sale | −2,503 | $20.68 | $52K | 9,490 |
| 2024-09-27 | GORMAN KEVIN CHARLES Director | Sale | −2,654 | $20.68 | $55K | 8,392 |
| 2024-09-27 | Montgomery Alan Bruce Director | Sale | −1,853 | $20.68 | $38K | 9,140 |
| 2024-09-27 | Feigal Ellen Director | Sale | −2,503 | $20.68 | $52K | 8,490 |
| 2024-07-10 | Desjarlais John R SR. VICE PRESIDENT & CSO | Option exercise | +7,785 | $10.73 | $84K | 200,104 |
| 2024-07-10 | Desjarlais John R SR. VICE PRESIDENT & CSO | Option exercise · Stock Option (Right to Buy) | −7,785 | 0 | ||
| 2024-07-09 | Desjarlais John R SR. VICE PRESIDENT & CSO | Option exercise | +42,215 | $10.73 | $453K | 228,648 |
| 2024-07-09 | Desjarlais John R SR. VICE PRESIDENT & CSO | Sale | −36,329 | $18.32 | $666K | 192,319 |
| 2024-07-09 | Desjarlais John R SR. VICE PRESIDENT & CSO | Option exercise · Stock Option (Right to Buy) | −42,215 | 7,785 | ||
| 2024-06-13 | Klencke Barbara Director | Grant or award | +5,986 | 5,986 | ||
| 2024-06-13 | Klencke Barbara Director | Grant or award · Stock Option (Right to Buy) | +11,971 | 11,971 | ||
| 2024-06-13 | ROSA-BJORKESON DAGMAR Director | Grant or award | +5,986 | 10,993 | ||
| 2024-06-13 | ROSA-BJORKESON DAGMAR Director | Grant or award · Stock Option (Right to Buy) | +11,971 | 11,971 |
Page 7 of 11 · 211 trades